Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14420
Articles
Company
Drug
Genor Biopharma Initiates First Patient Dosing for GB263T in China
February 3, 2025
Company
Drug
Akeso Biopharma Gains NMPA Approval for AK112 and AK119 Clinical Study
February 3, 2025
Company
Drug
Innovent Biologics Publishes Mazdutide Phase Ib Study Results for Obesity
February 3, 2025
Company
Deals
Sihuan Pharma to Acquire Additional Stake in Heilongjiang Duoduo Pharma
February 3, 2025
Policy / Regulatory
NHSA Completes Expert Review for NRDL Price Negotiation Process
February 3, 2025
Company
Drug
BeiGene’s Brukinsa Receives Positive CHMP Opinion for CLL Approval
February 3, 2025
Company
Drug
Kira Pharmaceuticals Gains NMPA Approval for Phase II Study of KP104 in PNH
February 3, 2025
Company
Drug
RemeGen’s Telitacicept Gains EU, China Approvals for Global Phase III Study
February 3, 2025
Company
Drug
Zelgen’s Jacktinib Shows Strong Efficacy in Phase III Myelofibrosis Study
February 3, 2025
Company
Deals
Ningbo Menovo to Sell Zhejiang Liaoyuan Pharma Stake to Jemincare for RMB 512.58M
February 3, 2025
Company
Deals
Ausper Biopharma Raises USD 16M for HBV Drug and Vaccine Development
February 3, 2025
Company
Deals
Alioth Biotech Raises RMB 100M in Series A Financing for Pharma Processing Products
February 3, 2025
1
2
…
1,116
1,117
1,118
1,119
1,120
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
